| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 01/24/2007 | CN1899613A Therapeutic polypeptide hepatitis B vaccine and its preparing method and using method |
| 01/24/2007 | CN1899612A Therapeutical peptide hepatitis C vaccine and its preparing method |
| 01/24/2007 | CN1899611A Therapeutical polypeptide hepatitis B vaccine and its preparing method |
| 01/24/2007 | CN1296355C Method for synthesis of perindopril and its pharmaceutically acceptable salts |
| 01/23/2007 | US7166709 Using high preformance liquid chromatography and gel permeation to purify heat resistant von willebrand factor (VDF) and antihemophilic factor from virally deactivated mixture; treating blood disorders |
| 01/23/2007 | US7166708 Reacting a protein with a hapten (especially a luteinizing hormone releasing hormone peptides derived from E coil, or malaria derived peptides) to produce a hapten-protein conjugate, followed by reacting the hapten-protein conjugate with a polysaccharide |
| 01/23/2007 | US7166707 Identifying peptide mimetic for treatment and prevention of tumors and autoimune diseases |
| 01/23/2007 | US7166702 Used to treat inflammatory responses associated with activation, proliferation and migration of immune effector cells, including leukocyte cell types, neutrophils, macrophages, and eosinophils |
| 01/23/2007 | US7166701 Human survivin interacting protein 1 (SIP-1) |
| 01/23/2007 | US7166698 Mammalian gene, bcl-w, belongs to the bcl-2 family of apoptosis-controlling genes |
| 01/23/2007 | US7166696 Solid phase synthesis supports and methods |
| 01/23/2007 | US7166691 Saposin C and receptors as targets for treatment of benign and malignant disorders |
| 01/23/2007 | US7166468 Using nucleic acid fragment; expression cassettes; cell libraries; open reading frames |
| 01/23/2007 | US7166446 Vector with nucleotide sequence that comprises a yeast-recognized transcription and translation initiation and termination region; coding amino acid sequence for hybrid precursor polypeptide linked to heterologous mammalian protein such as platelet derived growth factor; genetic engineering |
| 01/23/2007 | US7166436 Compound for use as diagnostic tool in protein analysis |
| 01/23/2007 | CA2309345C High throughput method for functionally classifying proteins identified using a genomics approach |
| 01/23/2007 | CA2208928C Selective stabilization of protein during viral inactivation |
| 01/18/2007 | WO2007009069A2 Heat lysis production of proteins |
| 01/18/2007 | WO2007008917A2 Modulation of protein functionalities |
| 01/18/2007 | WO2007008071A2 Method for detecting peptides comprising a cross-beta structure |
| 01/18/2007 | WO2007008069A2 A method for detecting peptides comprising a cross-b structure |
| 01/18/2007 | WO2006113958A8 Affinity ligands |
| 01/18/2007 | WO2006105448A3 Proliferation of muc1 expressing cells |
| 01/18/2007 | US20070016380 Protein engineering |
| 01/18/2007 | US20070015911 Methods for biomarker discovery and diagnostic screening |
| 01/18/2007 | US20070015270 Crystalline PDE4D2 catalytic domain complex, and methods for making and employing same |
| 01/18/2007 | US20070015254 Crystal harvest from fermentation broth |
| 01/18/2007 | US20070015143 Using a solid support linked to a polycyclic group that has an aromatic group fused to a heterocyclic ring that is substituted with a sulfate, sulfonate, phosphate, or phosphonate group through a sulfide or amine linking group |
| 01/18/2007 | US20070012568 analysis of a biological sample solution consisting of proteins, nucleic acids and carbohydrates; fluorescent dye reagent; bioassay |
| 01/18/2007 | DE10247896B4 Mehrdimensionale Trennung von Biosubstanzgemischen für massenspektrometrische Analysen Multidimensional separation of Biosubstanzgemischen for mass spectrometric analyzes |
| 01/18/2007 | DE102006003777A1 Vorrichtung zur Verarbeitung biologischer Proben Apparatus for processing biological samples |
| 01/18/2007 | DE102005033250A1 Verfahren zur Reinigung von G-CSF A method for purifying G-CSF |
| 01/18/2007 | CA2615025A1 A method for detecting peptides comprising a cross-.beta. structure |
| 01/18/2007 | CA2614941A1 Method for detecting peptides comprising a cross-beta structure |
| 01/18/2007 | CA2614341A1 Modulation of protein functionalities |
| 01/18/2007 | CA2613619A1 Sp1 polypeptides, modified sp1 polypeptides and uses thereof |
| 01/17/2007 | EP1743939A2 Method for isolation of RNA from formalin-fixed paraffin-embedded tissue specimens |
| 01/17/2007 | EP1742962A2 Methods and kits for folding proteins in the presence of linear or branched sugar polymers |
| 01/17/2007 | EP1742961A2 Inhibition of fgf signaling |
| 01/17/2007 | EP1078072B1 New peptide fragments for protein purification |
| 01/17/2007 | CN1898257A Methods for synthesis of encoded libraries |
| 01/17/2007 | CN1898254A New coupling agents for peptide synthesis |
| 01/17/2007 | CN1897969A Selective incorporation of 5-hyroxytrypophan into proteins in mammalian cells |
| 01/17/2007 | CN1896245A Production of gene recombinant fusion protein K1-EN |
| 01/17/2007 | CN1896103A N-terminally monopegylated polypeptides and process for their preparation |
| 01/17/2007 | CN1896095A Lucid ganoderma sugar peptide, its production and use |
| 01/16/2007 | US7164049 Process for the preparation of 3,3-dimethylbutanal |
| 01/16/2007 | US7164002 FVIIa antagonists |
| 01/16/2007 | US7163917 Synthesis method of alanylglutamine |
| 01/16/2007 | US7163803 Method for characterizing polypeptides |
| 01/16/2007 | US7163802 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 01/16/2007 | US7163793 Preparing immunoglobulins for use as tools in prevention of DNA and RNA degradation during molecular analysis; enzyme inhibitors |
| 01/16/2007 | US7163633 Combining an aqueous solution with an affinity matrix composed of a polymeric support, a dye attached to part of the support to enable optical detection of the affinity matrix, and an affinity ligand other than the dye attached to part of the polymeric support for the capture of the biomolecule |
| 01/16/2007 | CA2274071C Affinity based self-assembly systems and devices for photonic and electronic applications |
| 01/16/2007 | CA2103996C Dimer of molecular variant of apolipoprotein and processes for the production thereof |
| 01/11/2007 | WO2007005491A1 Hydrazide conjugates as imaging agents |
| 01/11/2007 | WO2007005389A1 F11 receptor (f11r) antagonists as therapeutic agents |
| 01/11/2007 | WO2007004748A1 Nucleic acid capable of binding to immunoglobulin g and use thereof |
| 01/11/2007 | WO2006089114A3 Methods and compositions for treating an anthrax toxin mediated condition |
| 01/11/2007 | WO2006083262A3 Method for enhanced accuracy in predicting peptides elution time using liquid separations or chromatography |
| 01/11/2007 | WO2006042263A3 Phosphoprotein affinity resins and methods for making and using the same |
| 01/11/2007 | US20070010673 Purification means |
| 01/11/2007 | US20070010661 Chromatography separation using apatite; protein being purified can comprise at least one constant antibody immunoglobulin domain |
| 01/11/2007 | US20070010660 G-CSF Conjugates |
| 01/11/2007 | US20070010655 Stationary phases and a purification process using the stationary phases |
| 01/11/2007 | US20070010453 Prodrugs of GABA analogs, compositions and uses thereof |
| 01/11/2007 | US20070009962 Nucleic acid binding polypeptide library |
| 01/11/2007 | US20070009960 Characterising polypeptides |
| 01/11/2007 | US20070009948 Nucleic acid binding polypeptide library |
| 01/11/2007 | US20070009605 Encapsulation of water soluble peptides |
| 01/11/2007 | US20070009520 Osteoclastogenesis inhibitory factor-binding molecule (OBM) specific immunoglobulin for use inhibiting osteoclast inhibitory factor (OCIF) binding activity and treating bone disorders |
| 01/11/2007 | US20070009506 Methods for production of recombinant urokinase |
| 01/11/2007 | US20070009477 Methods for rational PEGylation of proteins |
| 01/11/2007 | US20070007140 Magnetic locking mechanism for gel electrophoresis device |
| 01/11/2007 | US20070007139 Electrode for controlling/monitoring gel strips individually |
| 01/11/2007 | US20070007138 Modular system for gel electrophoresis device |
| 01/11/2007 | US20070007137 Ionic conducting gels, preparation method thereof and use of same |
| 01/11/2007 | CA2814736A1 Production of canola protein |
| 01/11/2007 | CA2814735A1 Production of canola protein |
| 01/11/2007 | CA2656741A1 Constrained hiv envelope-based immunogen that simultaneously presents receptor and coreceptor binding sites |
| 01/11/2007 | CA2614145A1 Nucleic acid capable of binding to immunoglobulin g and use thereof |
| 01/11/2007 | CA2613836A1 F11 receptor (f11r) antagonists as therapeutic agents |
| 01/11/2007 | CA2613439A1 Hydrazide conjugates as imaging agents |
| 01/10/2007 | EP1742062A2 Protein arrays for allelic variants and uses thereof |
| 01/10/2007 | EP1742058A2 Substrate for analyte determination and methods for manufacturing such substrates |
| 01/10/2007 | EP1741450A1 Composition for medical use having improved water-solubility of peptide and metal-labeling efficiency and preparation for medical use comprising metal-labeled peptide |
| 01/10/2007 | EP1740284A2 Separations platform based upon electroosmosis-driven planar chromatography |
| 01/10/2007 | EP1485129B1 Nanostructures containing pilin protein |
| 01/10/2007 | EP1337846B1 Arrangement for the production testing and archiving of chemical or biological arrays bonded to a solid phase |
| 01/10/2007 | CN1893972A Listeria-based EphA2 vaccines |
| 01/10/2007 | CN1891836A Quantitative measurement of gene expression based on paraffin-embedded tissue specimens |
| 01/10/2007 | CN1891717A Chemical modification method of endostatin and its use |
| 01/10/2007 | CN1891712A Method for designing and preparing small peptide high containing branched chain amino acids |
| 01/10/2007 | CN1891711A Method for preparing physiological active polypeptide of deer placenta |
| 01/10/2007 | CN1294261C Production method for recombinant silkworm antibacterial peptide CM4 |
| 01/10/2007 | CN1294256C Gene-expressed human tissue kallikrein protein separating and purifying method |
| 01/10/2007 | CN1294147C Combined process for producing animal blood fibronectin |
| 01/10/2007 | CN1294145C Crystal of methyl ester of alpha-L-asparaginyl-L-phenylalanine |
| 01/10/2007 | CN1294144C Process for producing soy-bean whey separator |
| 01/10/2007 | CN1294143C Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |